Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon
- HIV Testing and Treatment Among Tuberculosis Patients -- Kenya, 2006-2009. Sitienei, J.; Kipruto, H.; Nganga, L.; Ackers, M.; Odhiambo, J.; Laserson, K.; Nakashima, A. K.; Modi, S. // MMWR: Morbidity & Mortality Weekly Report;11/26/2010, Vol. 59 Issue 46, p1514
The article discusses a report on HIV data from Kenya's tuberculosis (TB) surveillance system from 2006 to 2009. The Kenya Division of Leprosy, Tuberculosis and Lung Disease (DLTLD) added HIV testing and treatment to its TB surveillance program at the recommendation of the World Health...
- Management of Tuberculosis in Children and New Treatment Options. Marais, B. J.; Schaaf, H. S.; Donald, P. R. // Infectious Disorders - Drug Targets;Apr2011, Vol. 11 Issue 2, p144
No abstract available.
- First WHO guidance on antiretrovirals in HIV prophylaxis. // PharmacoEconomics & Outcomes News;8/4/2012, Issue 659, p2
The article reports on the publication of the first guideline by the World Health Organization in August 2012 on the use of antiretrovirals in pre-exposure prophylaxis for the management of people who are at risk of HIV infection.
- What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings? Kenyon, Chris; Colebunders, Robert // PLoS Medicine;Aug2012, Vol. 9 Issue 8, p1
The authors discuss aspects the role of optimal first line antiretroviral therapy (ART) in resource-limited settings (RLS). They mention that its selection needs cautious balancing which involves effective regimens and costs. They note that such therapy can improve life expectancy as well as...
- Will Adoption of the 2010 WHO ART Guidelines for HIVInfected TB Patients Increase the Demand for ART Services in India? Kumar, Ajay M. V.; Gupta, Devesh; Rewari, B. B.; Bachani, Damodar; Mohammed, Suresh; Sharma, Vartika; Lal, Kumaraswamy; Reddy, H. R. Raveendra; Naik, Balaji; Prasad, Rita; Yaqoob, Mohammed; Deepak, K. G.; Shastri, Suresh; Satyanarayana, Srinath; Harries, Anthony David; Chauhan, Lakhbir Singh; Dewan, Puneet // PLoS ONE;2011, Vol. 6 Issue 9, p1
Background: In 2010, WHO expanded previously-recommended indications for anti-retroviral treatment to include all HIVinfected TB patients irrespective of CD4 count. India, however, still limits ART to those TB patients with CD4 counts <350/ mm3 or with extrapulmonary TB manifestations. We sought...
- HIV Treatment-as-Prevention Research at a Crossroads. Bärnighausen, Till; Eyal, Nir; Wikler, Daniel // PLoS Medicine;Jun2014, Vol. 11 Issue 6, p1
: In light of changing WHO guidelines for HIV treatment, Till BÃƒÂ¤rnighausen and colleagues consider how large-scale HIV treatment-as-prevention trials can be adapted so that they can remain viable. Please see later in the article for the Editors' Summary
- Role of the US President's Emergency Plan for AIDS Relief in Responding to Tuberculosis and HIV Coinfection. Coggin, William L.; Ryan, Caroline A.; Holmes, Charles B. // Clinical Infectious Diseases;May2010 Supplement 3, Vol. 50, pS255
The intersection of tuberculosis (TB) and human immunodeficiency virus (HIV) infection has eroded gains made in TB control, because previously well-functioning national TB programs have been overwhelmed by the dual challenges posed by TB and HIV coinfection. The US President's Emergency Plan for...
- Initial Response to Protease-Inhibitor-Based Antiretroviral Therapy among Children Less than 2 Years of Age in South Africa: Effect of Cotreatment for Tuberculosis. Reitz, Cordula; Coovadia, Ashraf; Ko, Stephen; Meyers, Tammy; Strehlau, Renate; Sherman, Gayle; Kuhn, Louise; Abrams, Elaine J. // Journal of Infectious Diseases;4/15/2010, Vol. 201 Issue 8, p1121
Background. South African guidelines recommend protease-inhibitor-based antiretroviral therapy (ART) with lopinavir-ritonavir for human immunodeficiency virus (HIV)-infected children <36 months of age.We investigated factors associated with viral suppression and mortality among young children...
- Monitoring of antiretroviral safety and efficacy. // WHO Drug Information;2004, Vol. 18 Issue 3, p228
The article reports that many countries in Africa are introducing combinations of antiretrovirals as part of the World health Organization's (WHO) 3 by 5 Strategy to provide antiretroviral treatment to 3 million people by 2005. A workshop has been organized by WHO in South Africa from September...